Save the date for ALK’s Capital Markets Day on 4 June 2024

26 Mar 2024
www.globenewswire.com
Immunotherapy
Save the date for ALK’s Capital Markets Day on 4 June 2024
ALK (ALKB:DC / OMX: ALK B / AKBLF) will host a Capital Markets Day on 4 June 2024 in the afternoon at the company’s headquarters in Hørsholm, Denmark.
At the Capital Markets Day, the Board of Management will elaborate on the results of the current strategy review.
An invitation will be sent out closer to the event.
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Maiken Riise Andersen, tel. +45 5054 1434
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,700 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
Attachment
ALK 26032024_Investor News_UK_CMD_Save the date


For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.